Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Net Margin (2016 - 2025)

Apyx Medical's Net Margin history spans 15 years, with the latest figure at 6.78% for Q4 2025.

  • For Q4 2025, Net Margin rose 2576.0% year-over-year to 6.78%; the TTM value through Dec 2025 reached 21.22%, up 2756.0%, while the annual FY2025 figure was 21.22%, 2756.0% up from the prior year.
  • Net Margin reached 6.78% in Q4 2025 per APYX's latest filing, up from 15.41% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 6.78% in Q4 2025 to a low of 73.96% in Q1 2024.
  • Average Net Margin over 5 years is 39.73%, with a median of 39.8% recorded in 2023.
  • Peak YoY movement for Net Margin: soared 7308bps in 2021, then tumbled -4645bps in 2024.
  • A 5-year view of Net Margin shows it stood at 11.95% in 2021, then plummeted by -303bps to 48.09% in 2022, then plummeted by -36bps to 65.52% in 2023, then skyrocketed by 50bps to 32.54% in 2024, then skyrocketed by 79bps to 6.78% in 2025.
  • Per Business Quant, the three most recent readings for APYX's Net Margin are 6.78% (Q4 2025), 15.41% (Q3 2025), and 33.22% (Q2 2025).